Intellia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Intellia Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTLA
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases.
CEOJohn M. Leonard
CEOJohn M. Leonard
Employees403
Employees403
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2014
Founded2014
Employees403
Employees403
NTLA Key Statistics
Market cap1.06B
Market cap1.06B
Price-Earnings ratio-2.14
Price-Earnings ratio-2.14
Dividend yield—
Dividend yield—
Average volume3.88M
Average volume3.88M
High today$9.27
High today$9.27
Low today$8.90
Low today$8.90
Open price$9.08
Open price$9.08
Volume3.95M
Volume3.95M
52 Week high$28.25
52 Week high$28.25
52 Week low$5.90
52 Week low$5.90
Stock Snapshot
With a market cap of 1.06B, Intellia Therapeutics(NTLA) trades at $9.15. The stock has a price-to-earnings ratio of -2.14.
On 2025-12-16, Intellia Therapeutics(NTLA) stock moved within a range of $8.90 to $9.27. With shares now at $9.15, the stock is trading +2.8% above its intraday low and -1.3% below the session's peak.
Trading activity shows a volume of 3.95M, compared to an average daily volume of 3.88M.
Over the past 52 weeks, Intellia Therapeutics(NTLA) stock has traded between a high of $28.25 and a low of $5.90.
Over the past 52 weeks, Intellia Therapeutics(NTLA) stock has traded between a high of $28.25 and a low of $5.90.
Analyst ratings
48%
of 27 ratingsBuy
48.1%
Hold
44.4%
Sell
7.4%
People also own
Based on the portfolios of people who own NTLA. This list is generated using Robinhood data, and it’s not a recommendation.